Invention Grant
US07994226B2 Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products 有权
使用半胱胺产品治疗非酒精性脂肪性肝炎(NASH)的方法

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
Abstract:
The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Information query
Patent Agency Ranking
0/0